PHAR (Pharming Group) Ending Cash Position : $54.9 Mil (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Pharming Group Ending Cash Position?

Pharming Group's Ending Cash Position for the quarter that ended in Dec. 2024 was $54.9 Mil.

Pharming Group's quarterly Ending Cash Position increased from Jun. 2024 ($47.1 Mil) to Sep. 2024 ($60.7 Mil) but then declined from Sep. 2024 ($60.7 Mil) to Dec. 2024 ($54.9 Mil).

Pharming Group's annual Ending Cash Position declined from Dec. 2022 ($207.3 Mil) to Dec. 2023 ($61.7 Mil) and declined from Dec. 2023 ($61.7 Mil) to Dec. 2024 ($54.9 Mil).

Pharming Group Ending Cash Position Historical Data

The historical data trend for Pharming Group's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharming Group Ending Cash Position Chart

Pharming Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

205.16

191.92

207.34

61.74

54.94

Pharming Group Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															61.74	51.89	47.14	60.66	54.94

Pharming Group Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Pharming Group's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	61.741	+	-6.797
	=	54.9

Pharming Group's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	60.662	+	-5.718
	=	54.9

Pharming Group Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Pharming Group's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharming Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharming Group (NAS:PHAR) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

PHGUF:USA PHARM:Netherlands PHARMa:UK 0QCO:UK PHGN:Germany

Address

Darwinweg 24, Leiden, ZH, NLD, 2333 CR

Website

https://www.pharming.com

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.